Document Detail

Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.
MedLine Citation:
PMID:  9130887     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To define the pathologic changes underlying the mechanism of shrinkage of uterine leiomyomata in patients treated with luprolide acetate. DESIGN: Retrospective study of pathologic changes seen in leiomyomata removed by hysterectomy or myomectomy in treated and untreated patients, matched by age and size of uteri and leiomyomata. PATIENT(S): Gross description and histologic slides of 30 treated and 30 untreated patients. INTERVENTION(S): Histologic examination performed blindly (without knowledge of treatment). Statistical work-up using chi 2 analysis with 1 df. MAIN OUTCOME MEASURE(S): Degree of hyaline and hydropic degeneration, cellularity, nuclear atypia, necrosis, and obliteration of interface. RESULT(S): Confluent nodular hyaline degeneration representing a scarlike retraction, geographic hydropic degeneration necrosis and obliteration of the interface between myoma and myometrium were found in higher proportions in the treated patients; differences in cellularity, nuclear atypia, and edema were not statistically significant. CONCLUSION(S): The decrease in size of the treated leiomyomata occurs as an accelerated postmenopausal shrinkage because of the antiestrogenic effect of the therapy. Obliterated cleavage planes may explain the difficult enucleation of myomatous nodules in some of the treated patients.
L Deligdisch; S Hirschmann; A Altchek
Related Documents :
16331537 - Likelihood of natural conception following treatment by ivf.
9782137 - Long-term economic evaluation of resectoscopic endometrial ablation versus hysterectomy...
8339817 - Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for e...
22735317 - Comparison between suture anchor and transosseous suture for the modified-broström pro...
8391147 - Inpatient vs outpatient treatment for substance dependence revisited.
18298357 - No difference between wearing a night splint and standing on a tilt table in preventing...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Fertility and sterility     Volume:  67     ISSN:  0015-0282     ISO Abbreviation:  Fertil. Steril.     Publication Date:  1997 May 
Date Detail:
Created Date:  1997-05-15     Completed Date:  1997-05-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  837-41     Citation Subset:  IM    
Mount Sinai Medical School, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents, Hormonal / therapeutic use*
Infant, Newborn
Leiomyoma / drug therapy,  pathology*,  surgery
Leuprolide / therapeutic use*
Lymphocytes / pathology
Middle Aged
Myometrium / pathology,  surgery
Retrospective Studies
Uterine Neoplasms / drug therapy,  pathology*,  surgery
Reg. No./Substance:
0/Antineoplastic Agents, Hormonal; 53714-56-0/Leuprolide
Comment In:
Fertil Steril. 1997 Nov;68(5):948-9   [PMID:  9389836 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cost-effectiveness of infertility treatments: a cohort study.
Next Document:  Chronobiologic evolution of luteinizing hormone secretion in adolescence: developmental patterns and...